Showing results (81-90 of 289) with videos related to
Sort By:
Pageof 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial responseMarcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Factors associated with self-reported physical and mental health after hematopoietic cell transplantationJohn R Wingard, I-Chan Huang, Kathleen A Sobocinski, et al.Cancer|June 22, 2010
Access to hematopoietic stem cell transplantation: effect of race and sexThomas V Joshua, J Douglas Rizzo, Mei-Jie Zhang, et al.Chest|July 9, 2005
Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemiaLinus H Santo Tomas, Fausto R Loberiza, John P Klein, et al.Blood|February 3, 2007
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimensRichard E Champlin, Waleska S Perez, Jakob R Passweg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and CanadaDerek S Serna, Stephanie J Lee, Mei-jie Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research StudyMohamed L Sorror, Brent R Logan, Xiaochun Zhu, et al.Blood|July 13, 2013
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)Wael Saber, Corey S Cutler, Ryotaro Nakamura, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methodsWael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 5, 2011
Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trialsEllen M Denzen, Martha E Burton Santibáñez, Heather Moore, et al.Pageof 29